Kaletra Tablet 200mg/50mg
Product details
Registration number: SIN13250P
Classification: Prescription Only
Active ingredients:
- Lopinavir
- Ritonavir
Strength:
- 200.0mg
- 50.0mg
Dosage form: TABLET, FILM COATED
Route: ORAL
Registrant: ABBVIE PTE. LTD.
ATC code: J05AR10
HSA approval date: 12 April 2007
Manufacturer(s): AbbVie Deutschland GmbH & Co. KG
Manufacturing country/countries: GERMANY
What are the HSA registration number and classification for Kaletra Tablet 200mg/50mg?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN13250P
Classification: Prescription Only
What active ingredients and strength are recorded for Kaletra Tablet 200mg/50mg?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Lopinavir
- Ritonavir
Strength:
- 200.0mg
- 50.0mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Kaletra Tablet 200mg/50mg?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, FILM COATED
Route: ORAL
Who is the recorded registrant for Kaletra Tablet 200mg/50mg?
According to the HSA dataset updated 7 August 2026:
Registrant: ABBVIE PTE. LTD.
Which manufacturers and countries are listed for Kaletra Tablet 200mg/50mg?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): AbbVie Deutschland GmbH & Co. KG
Manufacturing country/countries: GERMANY
Where can I look up Kaletra Tablet 200mg/50mg in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN13250P or the exact product name Kaletra Tablet 200mg/50mg. The general register link does not preselect this product.
What are the source dates for this Kaletra Tablet 200mg/50mg record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Kaletra Tablet 200mg/50mg record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN13250P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)